samedan logo
 
 
 
spacer
home > pmps > autumn 2008 > mes gets you to market quicker
PUBLICATIONS
Pharmaceutical Manufacturing and Packing Sourcer

MES Gets You to Market Quicker

Probably the biggest single driver for any manufacturer in the pharmaceutical industry has to be the time it takes to get a potential product through the research and development phases and out to market.

With R&D costs to bring a new drug to release approximated at $1 million a day, only when a product is in daily use does the huge investment undertaken by drug companies seeking the next blockbuster product begin to pay back.

There are plenty of examples, across many industries, of companies being late to market with a product, only to find further down the line that competitorsí products have subsequently appeared, with a resulting substantial hit in potential operating profits. Once a company is in the process of research...

Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
Mark Perry has held a number of senior positions, including Sales Director for ABB Process Instrumentation & Micro Control Systems and General Manager for Rockwell Automation EMEA Asset Management. He joined Siemens in 2003 as General Sales Manager for the Process Instrumentation Group before moving into the automation and drives process sector, heading up teams focusing on the chemical/pharmaceutical, food and beverage and oil and gas sectors. In 2007, Mark took up the position as Business Manager for the Siemens UK MES group, with responsibility for, among others, the pharmaceutical industry.
spacer
Mark Perry
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

Creating your Secondary Packaging Strategy

Pharmaceutical and biotechnology companies with a drug product in clinical development are usually focused on a quick commercial launch. Secondary packaging aspects are often less considered. Correlations with secondary packaging (in this context, secondary packaging also includes device assembly and serialization) that are not considered in this phase can have a negative effect on: ∑ further processability ∑ options in the product lifecycle management ∑ cost and time-to-market
More info >>

White Papers

Nanoparticle Tracking Analysis. A Review of Applications and Usage in the Analysis of Exosomes and Microvesicles

NanoSight

The study of exosomes and other cell-derived microvesicles is an area of rapidly growing importance and the subject of intense interest and research. The previous lack of suitable methods for their detection, analysis, enumeration and phenotyping is proving to be a significant limitation in these studies. This mini-review shows the degree to which the technique of Nanoparticle Tracking Analysis (NTA) is helping to address these problems.
More info >>

 
Industry Events

World Vaccine Congress Europe

18-21 October 2020, Barcelona, Spain

The World Vaccine Congress is an award-winning series of conferences and exhibitions that have grown to become the largest and most established vaccine meeting of its kind across the globe. Our credibility is show through the prestigious scientific advisory board that spend months of hard work creating a new and topical agenda, year on year.
More info >>

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement